Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Daily vs Weekly IV Methylprednisolone in Graves Orbitopathy
NCT06510114Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jul 2024
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of methylprednisolone in Graves' ophthalmopathy (TED), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
methylprednisolone
03
Conditions
Graves' ophthalmopathy (TED)
Beyond the preview
Go deeper on NCT06510114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06510114.